Oncogenes Proto-oncogenes

Proto-oncogenes normally function in controlling cellular growth. Proto-oncogenes are typically associated with cellular signal transduction and control of gene transcription. Oncogenes are tumor-causing, malignantly transformed (mutated) proto-oncogenes.
Growth Factor genes
Proto-oncogene/Oncogene type	Normal/Abnormal function
c-Sis	PDGF β-chain
v-sis gene (first oncogene with identified homology to known cellular gene)	oncogene in simian sarcoma virus
int-2 gene (integration of mouse mammary tumor virus)	FGF-related growth factor
KGF (Hst) gene	FGF-related growth factor oncogene in gastric carcinoma and Kaposi's sarcoma
Receptor Tyrosine Kinases ( RTKs)
c-Fms (“fims”) gene	colony stimulating factor-1 (CSF-1) receptor retroviral oncogene
Flg (“flag”) gene (homology to the Fms gene, so 'fms-like gene')	FGF receptor
Neu (“new”) gene – conversion of proto-oncogenic to oncogenic Neu requires only a single amino acid change in the transmembrane domain	EGF receptor-related gene in an ethylnitrosourea-induced neuroblastoma
Trk (“track”) genes – TrkA, TrkB and TrkC	NGF receptor-like proteins oncogene in pancreatic cancer
Met gene	hepatocyte growth factor(HGF)/scatter factor (SF) receptor
c-Kit gene	mast cell growth factor receptor
Membrane Associated Non-Receptor Tyrosine Kinases (PTKs)
v-src gene	first identified oncogene
c-Src gene	archetypal protein tyrosine kinase
Lck gene	T cell tumor line (LYSTRA cell kinase), associated with the CD4 and CD8 antigens of T cells
G-Protein Coupled Receptors (GPCRs)
Mas gene	angiotensin receptor oncogene in a mammary carcinoma
Membrane Associated G-Proteins
three different homologs of the c-Ras gene	most frequent oncogene in colorectal carcinomas
Serine/Threonine Kinases
Raf gene	signaling pathway of most RTKs, very likely threonine phosphorylation of MAP kinase following receptor activation
Nuclear DNA-Binding/Transcription Factors
Myc gene (disruption by retroviral integration and transduction and chromosomal rearrangements)	avian myelocytomatosis virus, human hematopoietic neoplasias
Fos gene	feline osteosarcoma virus, interacts with a second proto-oncogenic protein, Jun to form a transcriptional regulatory complex (AP1)
p53 gene (single most identified mutant protein in human tumors – originally identified as a major nuclear antigen in transformed cells)	Mutant forms of the p53 protein interfere with cell growth suppressor effects of wild-type p53 indicating that the p53 gene product is actually a tumor suppressor.

adapted from here.